Prof. Arturo Benayas Ayuso | Inventive Award | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Prof. Arturo Benayas Ayuso | Inventive Award | Best Researcher Award

Prof. Arturo Benayas Ayuso, Universidad Politécnica de Madrid, Spain

Arturo Benayas Ayuso is a seasoned naval architect with an MSc from the Universidad Politécnica de Madrid and currently pursuing a PhD focused on IoT applications in ship design and management. He serves as the Integration Lead for the “El Cano” platform at NAVANTIA, where he drives advancements in naval shipbuilding through industry 4.0 technologies and PLM processes. With extensive experience in PLM integration and software deployment, he has held various key roles, including Technical Account Manager for FORAN-PLM integration and Associate Manager at SENER. A multilingual professional fluent in Spanish, English, French, and Portuguese, Arturo has authored several papers and contributed to conferences on shipbuilding technologies. He also lectures on statistics at Universidad Complutense de Madrid, fostering the next generation of economists and business leaders. His technical expertise spans a wide range of programming languages, CAD/CAM/CAE systems, and PLM platforms, making him a pivotal figure in the maritime engineering field.

Professional Profile:

Scopus

Summary of Suitability for Best Researcher Award: Arturo Benayas Ayuso

Arturo Benayas Ayuso’s extensive qualifications and contributions to naval architecture and digital transformation in shipbuilding position him as an exceptional candidate for the Best Researcher Award. With a Master’s degree in Naval Architecture and ongoing PhD research focusing on IoT applications in ship design and management, he demonstrates a strong academic foundation.

Education:

  • MSc in Naval Architecture
    • Institution: Universidad Politécnica de Madrid
    • Year: 2005
    • Specialization: Marine motors specialist
  • PhD in Naval Architecture (ongoing)
    • Research Focus: IoT applied to Ship Design, Shipbuilding, Manufacturing, and Ship Management

Work Experience:

  • Digitization & PLM Associate Manager
    • Company: Accenture – Tecnilógica
    • Duration: 2020 – Present
    • Key Responsibilities:
      • Integration Lead for the “El Cano” platform at NAVANTIA, overseeing the design, building, deployment, and maintenance of naval ships.
      • Advising on PLM processes and validating software capabilities, functional specifications, and technical requirements.
      • Coordinating documentation for new tenders, including economic assessments.
      • Managing a fixed team of 7 and a floating development team of up to 10, utilizing Agile methodologies.
  • FORAN-PLM Technical Account Manager
    • Company: SENER, Ingeniería y Sistemas, S.A.
    • Duration: 2019 – 2020
    • Responsibilities: Managed the integration of FORAN for the migration of the Spanish S80P submarine and oversaw new developments for Windchill PLM integration.
  • Solution Architect Associate Manager
    • Company: SENER, Ingeniería y Sistemas, S.A.
    • Duration: 2012 – 2020
    • Responsibilities: Defined tasks for FORAN-PLM integration and led development teams focused on an OOTB (Out-of-the-Box) paradigm for Windchill and Teamcenter PLM.

Publication top Notes:

Internet of Things Cybersecurity: Blockchain as First Securitisation Layer of an IoT Network

Data management for smart ship or how to reduce machine learning cost in IoS applications

Automated/controlled storage for an efficient mbom process in the shipbuilding managing the iot technology

Carolin C. Hack | Medicine and Dentistry | Best Scholar Award

Published on | Editorial Board by World Top Scientists

Dr. Carolin C. Hack | Medicine and Dentistry | Best Scholar Award

Deputy clinical director at Erlangen University Hospital Women’s Clinic, Germany

Priv.-Doz. Dr. med. Carolin Christine Hack is an accomplished medical professional and the Deputy Director of the Women’s Clinic at the University Hospital Erlangen. With a specialization in gynecological oncology and integrative medicine, Dr. Hack combines her clinical expertise with a passion for patient-centered care. Her innovative approach to medicine, along with her extensive training and research, positions her as a leading figure in her field.

Profile

Scopus

Education 🎓

Dr. Hack completed her medical degree at Friedrich-Alexander University Erlangen-Nuremberg, where she also pursued her habilitation in “Integrative Medicine in the Treatment of Gynecological Oncology Patients.” Her academic journey included a comprehensive curriculum that laid the groundwork for her clinical and research interests, ultimately leading to a robust foundation in both conventional and integrative medicine.

Experience 💼

With over a decade of experience at the University Hospital Erlangen, Dr. Hack has advanced through various roles, from assistant physician to Deputy Director of the Women’s Clinic. She has managed quality assurance initiatives and specialized in integrative medicine, focusing on the intersection of traditional and complementary therapies in patient care. Her leadership in the clinic has fostered a collaborative environment that emphasizes innovative treatment methodologies.

Research Interests 🔍

Dr. Hack’s research primarily focuses on integrative medicine and complementary therapy methods, with a specific emphasis on mammographic density as a risk factor for breast cancer. Her work seeks to enhance patient outcomes through evidence-based practices that incorporate holistic approaches to treatment.

Awards 🏆

Dr. Hack’s contributions to gynecological oncology have been recognized with multiple awards, including:

  • 2015: Klaus-Dieter-Schulz-Versorgungsforschungspreis
  • 2016: First Science Award from the German Society for Senology
  • 2018: Award from the Foundation for Women and Child Health
  • 2022: Research Award for Complementary Medicine from NATUM e.V.

Publications 📚

Dr. Hack has an extensive publication record, including:

  • The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype
    • Authors: Ziegler, P., Hartkopf, A.D., Wallwiener, M., Schneeweiss, A., Goossens, C.
    • Journal: BMC Cancer
    • Year: 2024
    • Volume: 24(1), Article 1284
  • Tumor-Associated Neutrophils Are a Negative Prognostic Factor in Early Luminal Breast Cancers Lacking Immunosuppressive Macrophage Recruitment
    • Authors: Schmidt, E., Distel, L., Erber, R., Fietkau, R., Schnellhardt, S.
    • Journal: Cancers
    • Year: 2024
    • Volume: 16(18), Article 3160
  • Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
    • Authors: Fasching, P.A., Hack, C.C., Nabieva, N., Fehm, T.N., Häberle, L.
    • Journal: European Journal of Cancer
    • Year: 2024
    • Volume: 209, Article 114239
  • Correlation of RANK and RANKL with mammographic density in primary breast cancer patients
    • Authors: Wunderle, M., Heindl, F., Behrens, A.S., Fasching, P.A., Emons, J.
    • Journal: Archives of Gynecology and Obstetrics
    • Year: 2024
    • Volume: 310(2), pp. 1223–1233
  • CDK4/6 Inhibition – Therapy Sequences and the Quest to Find the Best Biomarkers – An Overview of Current Programs
    • Authors: Schneeweiss, A., Brucker, S.Y., Huebner, H., Fehm, T.N., Fasching, P.A.
    • Journal: Geburtshilfe und Frauenheilkunde
    • Year: 2024
    • Volume: 84(5), pp. 443–458
  • Initial experience with a next-generation low-field MRI scanner: Potential for breast imaging?
    • Authors: Dietzel, M., Laun, F.B., Heiß, R., Uder, M., Ohlmeyer, S.
    • Journal: European Journal of Radiology
    • Year: 2024
    • Volume: 173, Article 111352
  • Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer
    • Authors: Heger, L., Heidkamp, G.F., Amon, L., Beckmann, M.W., Dudziak, D.
    • Journal: OncoImmunology
    • Year: 2024
    • Volume: 13(1), Article 2296713
  • Predicting mammographic density with linear ultrasound transducers
    • Authors: Behrens, A., Fasching, P.A., Schwenke, E., Beckmann, M.W., Emons, J.
    • Journal: European Journal of Medical Research
    • Year: 2023
    • Volume: 28(1), Article 384
  • Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows
    • Authors: Lehle, S., Emons, J., Hack, C.C., Ruebner, M., Huebner, H.
    • Journal: Scientific Reports
    • Year: 2023
    • Volume: 13(1), Article 373
  • Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study
    • Authors: Hack, C.C., Maass, N., Aktas, B., Hein, A., Fasching, P.A.
    • Journal: Geburtshilfe und Frauenheilkunde
    • Year: 2023
    • Volume: 84(2), pp. 185–195

Conclusion ✨

Priv.-Doz. Dr. med. Carolin Christine Hack is an exemplary candidate for the Best Researcher Award. Her innovative contributions to integrative medicine and gynecological oncology, coupled with her extensive publication record and commitment to patient care, position her as a leader in her field. By addressing areas for improvement, such as interdisciplinary collaboration and public engagement, Dr. Hack can further enhance her impact in research and continue to advance the frontiers of medical knowledge.

Shahab Reaeian | Prevention | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Assoc Prof Dr. Shahab Reaeian | Prevention | Best Researcher Award

Academic member, Kermanshah University of Medical Sciences, Iran

Dr. Shahab Rezaeian is an esteemed epidemiologist from Iran, specializing in public health and epidemiology. With a PhD from Shiraz University of Medical Sciences, he has dedicated his career to understanding the dynamics of diseases and their impact on communities. He is currently a faculty member at Kermanshah University of Medical Sciences, contributing to the field through both research and education. 🩺📚

Publication Profile

Google scholar

Education

Dr. Rezaeian earned his B.S. in Public Health from Iran University of Medical Sciences in 2007, followed by an MSc in Epidemiology from Hamadan University of Medical Sciences in 2012. He completed his PhD in Epidemiology at Shiraz University of Medical Sciences in 2016, focusing his research on the survival trends and blood demand of beta-thalassemia patients. 🎓

Experience

Dr. Rezaeian has extensive experience in epidemiological research, particularly in assessing the risk factors for various health conditions, including congenital hypothyroidism and HIV. His professional journey reflects a commitment to advancing public health through rigorous data analysis and interpretation. 💼

Research Focus

His primary research interests include epidemiological modeling, public health interventions, and the study of congenital conditions. Dr. Rezaeian aims to contribute to effective health policies and practices by analyzing health data and identifying key determinants of health outcomes. 🔬📈

Awards and Honours

Dr. Rezaeian has received several accolades for his contributions to epidemiology and public health, including recognition for his impactful research publications and involvement in various health initiatives. His work continues to inspire future generations of health professionals. 🏆

Publication Top Notes

Dr. Rezaeian has authored numerous significant publications in reputable journals, contributing to the scientific community’s understanding of epidemiology and public health. Some notable works include:

Influenza A (H1N1) in Hamedan Province, Western Iran in 2009: A Case-Control Study (2010, J Res Health Sci) – Cited by 30

Quality of Cohort Studies Reporting Post the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement (2011, Epidemiology and Health) – Cited by 50

The Quality of the Reporting of Randomized Controlled Trials after CONSORT Statement in the Prestigious Journals (2013, Shiraz E Medical Journal) – Cited by 40

Difference in the Incidence of Congenital Hypothyroidism Among World Countries (2013, Ann Saudi Med) – Cited by 20

Social Determinants of Health Associated with Self-Reported HIV Testing Among Women (2013, Iran J Public Health) – Cited by 35

Risk Factors of Congenital Hypothyroidism Using Propensity Score: A Matched Case-Control Study (2013, J Res Health Sci) – Cited by 25

Salma Younes | Biomedical Sciences | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Ms. Salma Younes | Biomedical Sciences | Best Researcher Award

Salma Younes, Qatar University, Qatar

Profile

Google Scholar

Short Bio 🌟

Salma Younes, MSc, MLS (ASCP)CM, is a dedicated and accomplished Ph.D. candidate in Biomedical Science at Qatar University. With an impressive portfolio of 42 peer-reviewed publications and significant contributions to cancer research and biomedical nanotechnology, Salma is committed to advancing healthcare through innovative scientific solutions. Her exceptional academic performance and research efforts have earned her numerous awards and recognitions, marking her as a leader in her field. Currently, she serves as a Graduate Research Assistant while actively mentoring undergraduate and master’s students.

Education 🎓

Salma completed her Master of Science in Biomedical Sciences at Qatar University, graduating with a GPA of 3.65/4.00 in 2020. Her dissertation focused on the anticancer activity of guggulsterone in human leukemic cells. She earned her Bachelor of Science in Biomedical Sciences from the same institution in 2017, achieving a GPA of 3.10/4.00. Her undergraduate dissertation investigated the effects of iron chelation therapy on zebrafish models.

Experience 💼

Currently in her second year as a Ph.D. candidate and Graduate Research Assistant at Qatar University, Salma has extensive research experience. Previously, she worked as a Research Assistant at the Women’s Wellness and Research Center, Hamad Medical Corporation, and at the Biomedical Research Center of Qatar University. Salma also held a role as a Graduate Teaching Assistant, where she honed her teaching and mentoring skills, and served as a Lab Technologist at Qatar Biobank.

Research Interests 🔬

Salma’s research focuses on biomedical nanotechnology, particularly the synthesis and evaluation of novel 2D diphosphate nanocrystalline hydrogels for applications in skin infections and treatments. She is also deeply involved in cancer research, investigating molecular pathways and therapeutic strategies for chronic myeloid leukemia. Her commitment to public health is reflected in her studies on SARS-CoV-2 antibody responses and vaccine effectiveness.

Awards 🏆

Salma’s exceptional work has garnered several prestigious awards, including the Distinction in Academic Excellence from Qatar University in 2024 and the SIEED Innovation Pre-Incubation Program Award in both 2022 and 2023, where she received substantial funding for her research project. Additionally, she was recognized as the First Place Winner in the Graduate Research Award in Doha and was honored as a “Distinguished Graduate Student” by Qatar University in 2020, showcasing her dedication and impact in the field.

Publications 📚

Salma has contributed significantly to scientific literature, publishing in high-impact journals. Her key publications include:

  1. Younes, S., Nicolai, E., Pieri, M., Bernardini, S., Daas, H., Al-Sadeq, D., Younes, N., Shurrab, F., Nizamuddin, P., Humaira, F., Al-Dewik, N., Yassine, H., Abu-Raddad, L., Ismail, A. and Nasrallah, G. (2024). Follow-Up and Comparative Assessment of SARS-CoV-2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA-1273 Heterologous Booster Vaccination. Influenza Other Respi Viruses, 18: e13290. DOI: 10.1111/irv.13290.
  2. Younes, S., Nicolai, E., Al-Sadeq, D.W., Younes, N., Al-Dewik, N., Abou-Saleh, H., et al. (2023). Follow-up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals over 10 months. Journal of Infection and Public Health, 16(11): 1729-1735. DOI: 10.1016/j.jiph.2023.08.009.
  3. Younes, S., Zein, N., Abunasser, S., Kamareddine, L., Kirienko, N.V., Nasrallah, G.K. (2023). Editorial: Unconventional animal models in infectious disease research, volume II. Front Cell Infect Microbiol, 13: 1225129. DOI: 10.3389/fcimb.2023.1225129.
  4. Younes, S., Ismail, M.A., Al-Jurf, R., Ziyada, A., Nasrallah, G.K., Abdulrouf, P.V., et al. (2023). Management of chronic myeloid leukemia: current treatment options, challenges, and future strategies. Hematology, 28(1): 2196866. DOI: 10.1080/16078454.2023.2196866.
  5. Shurbaji, S., Al Tamimi, F., Al Ghwairi, M.M., El Chaar, D., Younes, S., Majdalawieh, A.F., et al. (2023). High-sensitive detection and quantitation of thyroid-stimulating hormone (TSH) from capillary/fingerstick and venepuncture whole-blood using fluorescence-based rapid lateral flow immunoassay (LFIA). Heliyon, 9(10): e20589. DOI: 10.1016/j.heliyon.2023.e20589.
  6. Al-Dewik, N., Samara, M., Younes, S., Al-Jurf, R., Nasrallah, G.K., Al-Obaidly, S., et al. (2023). Prevalence, predictors, and outcomes of major congenital anomalies: A population-based register study. Sci Rep, 13(1): 2198. DOI: 10.1038/s41598-023-27935-3.

Wei Meiqi | Exercise and health promotion | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Wei Meiqi | Exercise and health promotion | Best Researcher Award

PhD Candidate, Northeast Normal University, China

Meiqi Wei is a dedicated PhD candidate specializing in Exercise and Health Promotion at Northeast Normal University. Her academic journey began with a Bachelor’s degree in Sports Medicine from Shandong First Medical University, followed by a Master’s in Exercise and Human Science from Jilin University. She is actively engaged in research at the Chinese Center of Exercise Epidemiology, focusing on the integration of Big Data and AI with health promotion. Meiqi has published several influential papers and contributed significantly to interdisciplinary projects aimed at improving public health through data-driven insights.

Profile

Orcid

Education 🎓

Meiqi Wei’s educational background is marked by a strong foundation and advanced studies in sports and health sciences. She earned her B.S. in Sports Medicine from Shandong First Medical University. This was followed by an M.S. in Exercise and Human Science from Jilin University. Currently, she is pursuing her PhD in Exercise and Health Promotion at Northeast Normal University, where she continues to develop her expertise and contribute to her field.

Experience 💼

Throughout her academic career, Meiqi Wei has gained substantial experience in both research and practical applications of exercise and health sciences. She has been actively involved as a researcher in Computational Biology at the Chinese Center of Exercise Epidemiology. Her work spans several collaborative projects and consultancy roles, highlighting her ability to apply her research to real-world health challenges. Her experience is further solidified by her contributions to numerous high-impact scientific publications.

Research Interests 🔬

Meiqi Wei’s research interests lie at the intersection of Big Data, Artificial Intelligence, and Health Promotion. She focuses on leveraging computational biology methodologies to enhance epidemiological strategies. Her work aims to transform public health practices through data-driven insights, particularly in the areas of sarcopenia, physical fitness, and frailty in older adults. Her innovative approach seeks to improve the well-being of diverse populations by integrating advanced technological solutions into health promotion.

Awards 🏆

Meiqi Wei’s contributions to her field have been recognized through multiple nominations and accolades. She has authored three first-author SCI papers and published seven articles in indexed journals, three of which she led. Additionally, she holds two patents and has been involved in several high-profile collaborative projects. These achievements underscore her commitment to advancing health promotion through rigorous and impactful research.

Publications Top Notes📄

  1. Self-determined sequence exercise program for elderly with sarcopenia: A Randomized controlled trial with clinical assistance from explainable artificial intelligence
  2. Hybrid Exercise Program Enhances Physical Fitness and Reverses Frailty in Older Adults: Insights and Predictions from Machine Learning
  3. The Effectiveness of a Hybrid Exercise Program on the Physical Fitness of Frail Elderly
  4. Hybrid Exercise Program for Sarcopenia in Older Adults: The Effectiveness of Explainable Artificial Intelligence-Based Clinical Assistance in Assessing Skeletal Muscle Area